KELOWNA, BC / ACCESS Newswire / January 9, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, ...
Peer-reviewed publication in “The Oncologist” is now available onlineInvestigational same-day dosing of Rolvedon demonstrated a clinical response and adverse event profile similar to next-day ...
The "Latin America Industrial Cleaning Products Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering.The Latin ...
Vida has partnered with Aktis since co-leading its Series A, supporting the company from discovery through IPO and establishing itself as one of Aktis’ largest shareholders; Helen Kim, Vida Senior ...
Global Markets" has been added to ResearchAndMarkets.com's offering.The global protein expression market is poised for significant growth, with projections estimating an increase from $4.7 billion in ...
Enthorin Therapeutics, LLC, a biotechnology company focused on circuit-modulating treatments for neurological and neurodevelopmental disorders, announced that its licensing partner for MRM-3379 ...
Seasoned healthcare entrepreneur with multiple exits strengthens governance as the company advances durable glaucoma gene ...
Collaboration supports pre-IND development activities and establishes a structured path for potential next-stage development and commercializationWASHINGTON--(BUSINESS WIRE)--KeifeRx, a privately held ...
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: ...
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy ...
City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its ...
Experienced leader in preclinical and clinical drug development will support expansion of Company’s therapeutics pipeline for complex and common genetic diseasesCAMBRIDGE, England--(BUSINESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback